Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. MU
8. DFTX
9. HOOD
10. IBM

Go back to Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID
(NASDAQ: IVVD) Delayed: 0.91 -0.06 (6.19%)
Previous Close $0.97    52 Week High $ 
Open $0.96    52 Week Low $ 
Day High $0.99    P/E N/A 
Day Low $0.91    EPS $ 
Volume 4,104,925       

(NASDAQ: IVVD) Delayed: 0.91 -0.06 (6.19%)
Previous Close $0.97    52 Week High $ 
Open $0.96    52 Week Low $ 
Day High $0.99    P/E N/A 
Day Low $0.91    EPS $ 
Volume 4,104,925